PHARMING GRP SP. ADRS (PHG) — Cash Flow Quality Index

Latest as of December 2025: 2.01x

PHARMING GRP SP. ADRS (PHG) has a Cash Flow Quality Index of 2.01x as of December 2025. Operating cash flow of €10.71 Million exceeds net income of €5.33 Million, indicating high earnings quality where cash backs reported profits. Explore PHG cash generation efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

2.01x
Operating CF / Net Income

Operating Cash Flow

€10.71 Million
EUR

Net Income

€5.33 Million
EUR

Data as of

Dec 2025
Most recent filing

PHARMING GRP SP. ADRS Cash Flow Quality Index (2021–2025)

Historical Cash Flow Quality Index for PHARMING GRP SP. ADRS across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PHARMING GRP SP. ADRS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for PHARMING GRP SP. ADRS (2021–2025)

Year-by-year earnings quality comparison for PHARMING GRP SP. ADRS. For live market cap and the full company financial profile, see market value of PHARMING GRP SP. ADRS.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2025 19.19x €54.71 Million €2.85 Million ▲ +1068.4%
2022 1.64x €22.46 Million €13.67 Million ▼ -36.9%
2021 2.60x €37.84 Million €14.54 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.